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This study was carried out to assess the health status (serum biochemistry) of West African Dwarf 
(WAD) does administered varying levels of modroxyl-progestrone acetate (MPA), an oestrus 
synchronizing drug. The experiment was laid out in a completely randomized design. Result of the 
experiment showed that all the does were in good health status before, during and after the drug 
administration. Blood serum electrolytes analyses showed that all parameters assessed were within the 
normal range of a healthy goat. Sodium (Na
+
) mEq/L and potassium (K
+
) mEq/L were not significantly (P 
> 0.05) affected, by the drug administered. Urea (mg/dl) and creatinine (mg/dl) were significantly (P < 
0.05) influenced by the drugs administered. Serum enzymes activities in WAD does showed that alanine 
transaminase (ALT) (m/L) and aspartate transaminase (AST) (m/L) were not significantly affected (P > 
0.05) by administering MPA drug but alkaline phophatase (ALP) (mg/dl) was significantly (P < 0.05) 
influenced before and during the drug administration. Similarly, serum protein (g/dl) and serum glucose 
(mg/dl) values were significantly (P < 0.05) influenced before and during the drug administration. 
However, the result of this study showed that all the does were in good health status after 
synchronizing oestrus with the drug.  
 





Medroxyl progesterone acetate (MPA) is an estrus 
synchronizing drug; a hormonal compound which has 
hormonal effects that are largely due to its ability to 
suppress the secretion of pituitary gonatropins that in turn 
prevent follicular maturation, thus producing long term 
anovulation in reproductive female. 
The use of MPA to induce estrus in seasonal anaestrus 
and cycling ewes (Wildeus, 2004; Daniel et al., 2001) and 
does (Imasuen and Ikhimioya, 2009) has been well 
documented by several authors. However, its potential 
application on goats is yet to be fully explored, especially 
in our local breeds of goats such as West African Dwarf 
(WAD) does. Furthermore, there is the paucity of 
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drug may positively or otherwise interfere with the normal 
physiological process of the animal while trying to 
achieve oestrus manipulation with a view to harvest more 
kids from these animals. 
Consequently, this experiment was conducted to 
assess the likely changes that may occur in serum 
metabolites of WAD doe administered MPA drug with the 
specific objective of ascertaining if this drug will cause 
any health problem in does administered varying doses 
of MPA drug. 
 
 
MATERIALS AND METHODS 
 
Description of location and site of experiment  
 
The experiment was carried out at the Teaching and Research 
Farm, Faculty of Agriculture, Ambrose Alli University, Ekpoma in 
Edo State, Nigeria.  The  experimental  site  lies  along  latitude  6½  




degree North and latitude 6 degree North located in the rainforest 
zone of Nigeria with an average annual rainfall of about 1500 to 
2000 mm per annual and relative humidity of about 75% with a 
mean temperature of 24°C(Frederick et al., 2007).  
 
 
Animals and management  
 
Forty (40) cycling West African Dwarf (WAD) does used for this 
experiment were purchased directly from local farmers rather than 
buying from the open market so as to guarantee the quality of stock 
used. 
Only does with four to six broad central teeth were purchased. 
This was done to ensure that only does that are cycling and 
between two to three years of age and weighing an average of 
16.59 ± 0.76 kg as well as had kidded once or twice were used for 
the experiment. This was done using the dentition and weight range 
methods as outlined by Sastry and Thomas (1975) and Devendra 
and Mcleroy (1983). Prior to the commencement of the experiment, 
all does were quarantined for 30 days during which routine 
treatment developed by NAPRI (1984) was administered under the 
supervision of a veterinarian. 
At the end of the quarantine period, the animals were randomly 
assigned to five treatment groups and each treatment group was 
assigned eight WAD does. The animals were separated into the 
treatment groups based on the route of administration and dosage 
of the drug administered. The five treatment groups consisted of the 
following: treatment 1: does administered 25 mg MPA (Depo - 
provera®) intramuscular injection, single dose; treatment 2: does 
administered 50 mg MPA (Depo - provera®) intramuscular 
injection, single dose; treatment 3: does administered 5 mg MPA 
(provera®) orally for ten days; treatment 4: does administered 10 
mg MPA (provera®) orally for ten days; treatment 5: does 
administered 5 ml sterile water orally for ten days (this group served 
as the control group). 
The dosage of medroxyl-progesterone acetate (MPA) used in this 
experiment was as a result of the fact that this drug comes in an 
injectable form (Depo-provera®) and orally active tablets 
(provera®). The tablet form comes in 5 or 10 mg; therefore it was 
convenient to administer single tablets of 5 or 10 mg per day for 10 
days. Also, the injectable form (Depo-provera®) was half the tablet 
form (provera®) because the injectable form is a long acting drug, 
which is always administered as a single dose. 
The animals used for the experiment were identified individually 
with neck tags encoded according to treatment groups. All animals 
were managed semi-intensively. They were fed in the mornings 
between 8.00 and 10.00 h daily with Arachis hypogea (groundnut) 
hay, Giliricidia sepium, Panicum maximum and occasionally, Zea 
mays (maize) or Manihot esculenta (cassava) peelings, when 
available, before allowing them to go out from their pens into the 
adjoining fenced paddock. The animals were allowed to remain in 
the paddock to graze freely between the 10.00 and 18.00 h before 
allowed to return to their pens for confinement. Water and salt lick 
were provided ad libitum. 
The experiment was carried out in three stages. The first stage of 
the experiment involved the acclimatization and stabilization of 
cycling does used for this experiment. Blood sample was collected 
from each experimental animal twice during this stage and the 
average of the result was used as pre-drug administration 
information. 
The second stage lasted for two weeks during which the drug 
was administered and blood sample was also collected twice during 
drug administration, with the average of the result used as during-
drug administration.  
The third stage involved blood collection two weeks after drugs 
withdrawal from the does. Blood sample was also collected twice 
during the third and fourth weeks after drug withdrawal, and the 





Determination of serum biochemistry  
 
Total protein, albumin, globulin, glucose, creatinine and urea were 
determined using the methods described by Dacie and Lewis 
(1991), while sodium (Na
+
) and potassium (K
+
) were determined by 
flame photometry (Hawk et al., 1954). 
 
 
Determination of serum enzymes activities  
 
Serum alanine tranaminase (ALT), serum aspartate transaminase 
(AST) and serum alkaline phosphatase (ALP) were analysed 
spectrophotometrically, using commercially available diagnostic kits 
(RANDOX
®
 Test Kits).  
 
 
Statistical analysis  
 
All data collected were subjected to analysis of variance using the 
SAS/STAT (2004) package. Mean separations were done using the 
same software, where there were indications of significant 





The blood sera assessed in this experiment were serum 
electrolytes, serum enzymes activities and serum glucose 
and protein. These results are shown in Tables 1, 2 and 
3. The result of the blood serum electrolytes showed that 
serum sodium (Na
+
) and potassium (K
+
) ions assessed 
were not significantly (P > 0.05) influenced by the drug 
administered within all the treatments, although signi-
ficant differences (P < 0.05) existed between the control 
animals and other animals when K
+
 was assessed 
between treatments during and after drug administration. 
The level of urea in the blood serum showed that the 
drug administered significantly increased urea level 
during the period of drug administration within all the 
treatments, except in the control. In serum creatinine, the 
significant differences observed within and between the 
treatments did not follow any define pattern and could 
therefore not be strictly attributed to the drug 
administered. 
The result of enzymes activities in the blood serum as 
shown in Table 2, revealed that ALT and AST were not 
significantly (P > 0.05) influenced between and within all 
the treatments. ALP values showed significant (P < 0.05) 
decrease within treatments 2 and 4 after drug withdrawal. 
Similar significant (P < 0.05) differences were observed 
between treatments during drug administration. 
Serum protein values as shown in Table 3 revealed 
that there were significant decrease (P < 0.05) within all 
the treatments post-drug administration, except in the 
control group. Similar increases were observed between 
the treatments during the drug administration. 
Albumin and globulin values did not reveal any signify-
cant change (P > 0.05) during the drug administration. 
Conversely, glucose values were significantly (P < 0.05) 
influenced in treatments 3 and 4, as increase was 
observed during drug administration.  









(25 mg Depo) 
TRT 2 
(50 mg Depo) 
TRT 3 
(5 mg Provera) 
TRT 4 
(10 mg Provera) 
TRT 5 
(Control) 
Pre-drug administration      
Sodium (Na
+
) (mEq/l) 141.00 ± 0.71
a
(x) 139.25 ± 1.25
a
(x) 139.50 ± 1.19
a
(x) 140.50 ± 1.19
a





) (mEq/l) 4.50 ± 0.18
a
(x) 4.68 ± 0.47
a
(x) 4.50 ± 0.07
a
(x) 4.83 ± 0.43
a
(x) 4.33 ± 0.18
a
(x) 
Urea (mg/dl) 22.50 ± 0.07
a
(z) 29.75 ± 4.76
a
(x) 23.00 ± 5.60
a
(z) 32.50 ± 3.23
a
(x) 26.50 ± 4.97
a
(x) 
Creatinine (mg/dl) 0.65 ± 0.7
a
(y) 0.75 ± 0.13
a
(x) 0.78 ± 0.13
a
(x) 0.70 ± 0.06
a
(y) 0.65 ± 0.07
a
(x) 





     
139.50 ± 0.65
a
(x) 140.50 ± 1.04
a
(x) 141.00 ± 0.41
a
(x) 139.50 ± 0.65
a





) (mEq/l) 4.30 ± 0.18
ab
(x) 4.50 ± 0.22
ab
(x) 5.03 ± 0.21
a
(x) 4.83 ± 0.48
a
(x) 3.85 ± 0.05
b
 (x) 
Urea (mg/dl) 32.50 ± 2.96
a
(x) 30.75 ± 3.95
a
(x) 32.50 ± 2.33
a
 (x) 31.50 ± 2.53
a
(x) 28.00 ± 3.08
a
(x) 
Creatinine (mg/dl) 1.03 ± 0.05
a
(x) 0.80 ± 0.04
ab
(x) 0.90 ± 0.04
ab
(x) 1.00 ± 0.04
a
(x) 0.73 ± 0.08
b
(x) 





     
139.00 ± 1.08
a
(x) 140.75 ± 1.10
a
(x) 140.50 ± 0.87
a
(x) 139.0 ± 1.08
a





) (mEq/l) 4.25 ± 0.25
ab
(x) 4.48 ± 0.19
ab
(x) 4.80 ± 0.36
ab
(x) 4.98 ± 0.36
a
 (x) 3.93 ± 0.10
b
(x) 
Urea (mg/dl) 29.50 ± 2.72
 a
(y) 27.75 ± 3.57
 a
(y) 28.25 ± 5.33
 a
(y) 27.50 ± 3.07
 a
(y) 27.00 ± 1.73
 a
(x) 
Creatinine (mg/dl) 0.70 ± 0.04
ab
(y) 0.87 ± 0.05
a
(x) 0.80 ± 0.11
ab
(x) 0.85 ± 0.14
ab




a, b: Values with different superscript along the same row (between treatments) are significantly different (P < 0.05); x, y, z: values with corresponding parameters in 




Other significant differences observed among 
the treatments did not follow any define pattern 








) is the major cation of the 
intracellular fluid and functions as sodium does in 
the extracellular fluid by influencing acid base 
balance (Adedeji, 1992; Guyton, 1985). 
This mineral plays a vital role in muscle 
function. High blood levels of potassium are gene-
rally due to kidney failure or endocrine disease 
rather than from excessive dietary intake. There is 
a relationship between sodium and potassium 
metabolism (Campbell et al., 2003). Similarly, 
sodium ion is important for normal muscles 
contraction. It is also essential for maximum 
utilization of dietary energy and protein, and for 
efficient reproduction. On this premise therefore, 
potassium and sodium ion assessment in this 
study revealed that these two essential element 
were not significantly affected by the drug 
administered as all values obtain from the study 
fell within the range of 3.0 to 6.0 mmol/L for 
potassium ion and 124 to 146 mmol/L for sodium 
ion as reported by Daramola et al. (2005) for WAD 
goats. However, report from temperate region 
shows a higher range of value for goats, sheep 
and cattle (Harper, 1982). 
In this respect, WAD goats are probably similar 
to man and cattle which have been shown to have 
lower sodium level in tropical environment 
(Macfarlane et al., 1970; Oduoye and Fasanmi, 
1971). This close association between tropical 
environment and lower sodium level in man has 
been attributed to variable dietary intake of salt 
and loss of sodium and chlorine ions in urine 
under tropical environmental condition (Macfarlane 
et al., 1970). 









(25 mg Depo) 
TRT 2 
(50 mg Depo) 
TRT 3 
(5 mg Provera) 
TRT 4 
(10 mg Provera) 
TRT 5 
(Control) 
Pre-drug administration      
ALP (mg/dl) 98.75 ± 22.72
b
(x) 187.00 ± 50.35
a
(x) 86.75 ± 11.38
b
(y) 117.25 ± 13.20
a,b
(x) 54.75 ± 16.84
 b
(x) 
ALT (µ/l) 10.25 ± 2.95
 a
(x) 8.50 ± 1.32
 a
(x) 9.00 ± 1.68
 a
(x) 8.50 ± 2.10
 a
(x) 11.00 ± 2.27
 a
(x) 
AST (µ/l) 62.75 ± 4.51
 a
(x) 70.50 ± 10.57
 a
(x) 69.50 ± 7.59
 a
(x) 65.00 ± 4.25
 a
(x) 56.25 ± 1.10
 a
(x) 
      
During–drug administration 
ALP (mg/dl) 
     
93.25 ± 4.40
 b
 (x) 140.50 ± 34.51
 a
(x) 117.00 ± 52.81
 a
(x) 165.75 ± 43.27
 a
(x) 75.50 ± 12.34
 c
(x) 
ALT (µ/l) 12.75 ± 1.10
 a
(x) 9.00 ± 0.91
 a
(x) 10.00 ± 1.08
 a
(x) 11.75 ± 2.68
 a
(x) 11.50 ± 1.19
 a
(x) 
AST (µ/l) 61.00 ± 2.48
 a
(x) 65.25 ± 5.21
 a
(x) 73.00 ± 5.84
 a
(x) 67.75 ± 6.14
 a
(x) 59.25 ± 3.06
 a
 (x) 
      
Post–drug administration 
ALP (mg/dl) 
     
79.25 ± 9.23
 a
(x) 101.75 ± 15.29
 a
(y) 105.00 ± 1.42
 a
(x) 84.75 ± 4.75
 a
(y) 78.25 ± 15.64
 a
 (x) 
ALT (µ/l) 10.75 ± 1.25
 a
(x) 8.50 ± 2.50
 a
(x) 10.50 ± 1.04
 a
(x) 11.50 ± 1.55
 a
(x) 6.00 ± 1.68
 a
 (x) 
AST (µ/l) 65.50 ± 3.81
 a
(x) 63.25 ± 5.31
 a
(x) 75.50 ± 6.70
 a
(x) 67.75 ± 4.42
 a




a, b, Values with different superscript along the same row (between treatments) are significantly different (P < 0.05); x, y, values with corresponding parameters in parenthesis 




Urea and creatinine were the other blood meta-
bolite assessed and the results showed that these 
metabolites were significantly increased (P < 0.05) 
during the drug administration and significantly 
was decreased (P < 0.05) after drug withdrawal in 
all the treatment groups, except in treatments 2 
and 3, where differences were not observed in 
creatinine value at the different stages  studied. 
The increase or decrease in the urea and 
creatinine values during drug administration and 
drug withdrawal agrees with previous findings of 
Sathyamorthy et al. (1981). They reported increa-
se in serum urea and creatinine in rat. They 
reported that any endogenous toxic substance 
might manifest through reduced protein utilization, 
thereby increasing the catabolism of amino acid, 
which would be subsequently degraded into urea 
and creatinine. Accurate determination of 
creatinine clearance is crucial to rational drug 
therapy because many drugs are either partially or 
totally eliminated by the kidney. Creatinine 
clearance is the most accurate test of renal 
function (Kassirer, 1971). The value of creatinine 
in this experiment was slightly below the value 
reported for goat and sheep (Schalm et al., 1975) 
but fell within the range reported for man (Adedeji, 
1992). 
It is a known and accepted fact that tissues 
soluble enzymes are very vital adjunct to clinical 
diagnosis of tissue damage and disease. Both 
ALT and AST in conjunction with other enzymes 
are indicators of liver and other body tissue 
damage (Retiman and Frankel, 1957; Rosalki and 
Wilkiron, 1976). ALT is involved in cellular 
metabolism and energy processes of the cell, 
while AST is involved in the inter-conversion of 
glutamate to α-ketoglutamate in the cytoplasm 
and mitochondria of the cell. Consequently, chan-
ges in ALT and AST levels are indicators of liver 
damage and muscle necrosis (Rosalki and 
Wilkiron, 1976; Mitruka and Rawnsley, 1977).  
In this study, serum alanine transaminase level 
was found not to be significantly increased during 
the course of drug administration and drug 
withdrawal. This is contrary to the report of 
Adedeji (1992) that oral administration of 
progestin-estrogen combination may elevate 
serum ALT and AST. Another factor that may 
elevate this serum enzymes activity is the plane of 
nutrition. Schimke (1962) stated that the levels of 
serum and liver ALT and AST frequently  increase  




Table 3. Serum proteins and glucose estimation in WAD does administered MPA drug.  




(25 mg Depo) 
TRT 2 
(50 mg Depo) 
TRT 3 
(5 mg Provera) 
TRT 4 
(10 mg Provera) 
TRT 5 
(Control) 
Pre-drug administration      
Total Protein (g/dl) 7.80 ± .51
bc
(x) 6.07 ± 0.45
c
(y) 8.85 ± 0.78
ab
(x) 9.75 ± 0.47
a
(x) 7.75 ± 0.52 
bc
(x) 
Albumin (g/dl) 3.22 ±  .35
 a
(x) 3.67 ± 0.22
 a
(x) 3.75 ± 0.15
 a
(x) 3.92 ± 0.34
 a
(x) 3.40 ± 0.08
 a
(x) 
Globulin (g/dl) 4.58 ± . 67
a
(x) 2.40 ± 0.27
 a
(x) 5.10 ± 0.86
 a
(x) 5. 83 ± 0.57
 a
(x) 4.35 ± 0.49
 a
(x) 
Glucose (mg/dl) 44.75 ± .1.18
b
(x) 46.75 ± 3.77
b
(y) 60.25 ± 6.73
a
(y) 56.00 ± 5.55
ab
(y) 43.50 ± 1.44
b
(y) 
      
During–drug administration 
Total Protein (g/dl) 
     
7.15 ± 0.98
bc
(x) 7.52 ± .40
abc
 (x) 8.95 ± 0.54
ab
(x) 9.50 ± 0.64
a
 (x) 6.52 ± 0.35
c
 (x) 
Albumin (g/dl) 3.35 ± 0.51
 a
(x) 3.57 ± .19 
a
 (x) 3.72 ± 0.25
 a
(x) 3.90 ± 0.30
 a
 (x) 3.17 ± 0.41
 a
 (x) 
Globulin (g/dl) 3.80 ± 0.47
 b
(x) 3.95 ± .22
 b
 (x) 5.23 ± 0.47
a
(x) 5.60 ± 0.61
a
 (x) 3.35 ± 0.13
b
 (x) 
Glucose (mg/dl) 49.50 ± 3.42
b




(x) 74.25 ± 1.75
a
(x) 53.25 ± 5.452
b
(x) 
      
Post–drug administration 
Total Protein (g/dl) 
     
6.10 ± 0.15
 a
(y) 6.60 ± 0.56
 a
(y) 7.20 ± 0. 23
 a
(y) 7.17 ± 0. 28
 a
(y) 6.50 ± 0.33
 a
(x) 




(x) 3.45 ± 0. 29
 a
(x) 3. 40 ± 0. 08
 a
(x) 3.05 ± 0.9
 a
(x) 
Globulin (g/dl) 3.15 ± 0.08
 a
(x) 3.38 ± 0.46
 a
(x) 3.75 ± 0.31
 a
(x) 3.77 ± 0.27
 a
(x) 3.45 ± 0.9
 a
(x) 
Glucose (mg/dl) 49.00 ± 5.49
 a
(x) 50.25 ± 3.56
 a
(x) 56.75 ± 3.04
 a
(y) 52. 50 ± 7.08
 a




a ,b c: Values with different superscript along the same row (between treatments) are significantly different  (P < 0.05);  x, y: values with corresponding parameters in 




in response to decrease in energy intake while 
Ekpenyong and Biobaku (1986) reported that 
bone demineralization as a result of poor plane of 
nutrition may increase serum ALT and AST. 
ALP constitutes a large group of isoenzymes, 
which plays important roles in the transportation of 
sugar and phosphate and originate from different 
tissues such as liver, bone, placenta and intestine 
(Adedeji, 1992). In normal adult, according to 
Adedeji (1992), the two main sources of ALP are 
bone and liver. Consequently, an elevation of 
alkaline phosphatase may be a result of either 
liver problem or bone disease. The same author 
also reported the elevation of serum alkaline 
phosphatase as a result of administration of 
progestin-estrogen drug. 
The significant difference (P < 0.05) observed in 
this study (Table 2) may therefore be attributed to 
the drug administered, possibly due to its 
metabolic effects in the liver and bones. It is 
however not certain why no effect was observed 
in treatments 1and 3 during and after the drug 
withdrawal.  
Plasma proteins serve as sources of rapid 
replacement of tissue proteins, as buffer in acid-
base balance, and as transporters of constituents 
of blood such as vitamins, iron, copper, 
hormones, lipids and certain enzymes (Adedeji, 
1992). About, 65% of the body total protein is 
albumin, which is produced by the liver, alongside 
globulin. Hansten (1980) reported that progestin-
estrogen drug might elevate total plasma protein. 
Furthermore, the plane of nutrition has also been 
reported to affect total serum protein level 
(Bamgbose et al., 2004; Babatunde et al., 1992). 
In this study, no significant effect was observed 
during the drug administration, except in treatment 
2 where increase was observed. It seems 
therefore that the drug had a delayed effect as 
there was significant decrease in the level of 
serum total protein in post drug administration 
period for each treatment group in which the drug 




was administered (Table 3).  
Since the serum albumin and globulin levels were not 
significantly altered either during the drug administration, 
the difference observed in the total protein value could be 
attributed to the contribution of other protein sources in 
the blood. 
Except in treatment 1 (Table 3), glucose value was 
significantly increased (P < 0.05) within treatments during 
drug administration. This increase seemed not to be 
related to the drug as similar increase was noticed in the 
control. For similar reason, it is difficult to explain the 
sustained increases observed among other treatments 
during the different stages of the experiment. 
The observation in this case contradicts the report of 
Hansten (1980) who suggested that progesterone–
oestrogen combination drug causes increase in the level 
of serum glucose. The contrary observation may be 
related to the absence of oestrogen in the drug; this is 
because synergistic effect of the progesterone and 





Oestrus synchronization is one of the major scientific 
approaches currently employed to overcome the low 
reproductive ability of WAD goats as experienced in the 
traditional system of goat production in Nigeria. It was 
observed that administration of MPA drug could cause 
significant changes in body weight gain in WAD dose 
(Imasuen and Ikhimioya, 2009) and to some extent, alter 
the serum biochemistry of the animal. 
Blood serum metabolite and serum enzymes such as 
urea, creatinine and alkaline phosphate evaluated during 
this experiment were found to be significantly (P < 0.05) 
influenced by the MPA drug administered, however, the 
degree was not such that was deleterious and therefore 
did not suggest ill health in the WAD does. Also, the 
significant (P < 0.05) increases observed in serum protein 
and glucose during the drug administration are all 
indication that MPA drug used in synchronizing oestrus 
could alter the overall physiological status of goats 
administered MPA drug.  
Finally, the use of MPA drug in achieving oestrus 
synchronization in WAD does should be guided by the 
dose and rate of administering the drug so as not to 
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